Recombinant Human BD-5 #abs00950

abs00950-5ug

1-2 Weeks

138

abs00950-20ug

1-2 Weeks

344

abs00950-1mg

1-2 Weeks

3891

Source

Escherichia coli.

Format

The concentrated solution in PBS, pH 7.4, was subjected to filtration with a 0.2 μm filter before being lyophilized. A highly similar content can be generated by rearranging this information.

Properties

aa_sequence

CEGFSQKPLF ECGKAFVSEC CLENRPDKNE CEGKRCRGLR QRCRCCFLNL ENPDKCGNCL.

Concentration

> 95 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

According to the LAL method, the Recombinant Human BD-5 contains less than 1.0 EU/μg. It is important to note that this information is derived from the original text.

Activity

Testing in progress.

Reconstitution

To ensure the proper mixing of the contents, we suggest briefly centrifuging the vial before opening. To reconstitute, using sterile distilled water or an aqueous buffer containing 0.1% BSA, create a solution with a concentration of 0.1-1.0 mg/ml. Divide the stock solution into working aliquots and store them at ≤ -20°C. Dilute further in appropriate buffered solutions for use. Keeping these guidelines in mind will ensure optimal results.

Stability & Storage

For optimal storage and preservation of this lyophilized preparation, it is recommended to follow specific temperature conditions. While it can be stored stably at 2-8 °C, it is advisable for long term storage to keep it at -20 °C, preferably in a desiccated state. Once reconstituted, the preparation maintains stability for a period of one week when stored at 2-8 °C. To ensure longevity and maximum stability, it is suggested to divide the reconstituted preparation into smaller working aliquots and store them at temperatures ranging from -20 °C to -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles as it may compromise its integrity and efficacy.

Target

Accession

Q8NG35

Gene IDs

245908